The injectable monoclonal antibody prevents respiratory syncytial virus in newborns and infants during their first RSV season and at-risk children during their second RSV season.
Doctors say they are seeing an unusual spike in walking pneumonia cases in parts of Canada, particularly in kids, but their message for parents is not to panic.